Immunovant (IMVT) COO Gloria Melanie Sells Shares

What Happened

• Gloria Melanie, Chief Operating Officer of Immunovant, sold 3,056 shares on August 20, 2026, for total proceeds of approximately $134,953. The reported weighted-average sale price was $44.16 per share (individual sale prices ranged $43.80–$44.37).
• The sale was not a discretionary trade: it was a mandated "sell-to-cover" to satisfy tax withholding upon the vesting and settlement of RSUs originally granted on November 18, 2024 (109,956 RSUs total; 6,872 RSUs vested on August 18, 2026).

Key Details

• Transaction date: 2026-08-20; weighted-average price $44.16; price range $43.80–$44.37 (multiple trades).
• Shares sold: 3,056; proceeds: ~$134,953.
• Shares owned after the transaction: not specified in the provided excerpt of the filing.
• Notable footnotes: F1 — sale made to cover tax withholding on vested RSUs (mandated by issuer); F2 — price is a weighted average and the reporting person can provide per-trade pricing upon request.
• Filing timing: Report filed 2026-08-21 for a transaction on 2026-08-20 (appears timely).

Context

• This was a routine sell-to-cover tied to RSU vesting, which is common and generally does not reflect a discretionary view on the company by the insider. The underlying RSU grant and vesting schedule are the driving factors for the sale, not an open-market decision to reduce exposure.